Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 162Lung Neoplasms 53Neoplasms 14Neoplasm Metastasis 10NSCLC 10Brain Neoplasms 10Carcinoma 9Meningeal Carcinomatosis 6Colorectal Neoplasms 5Bronchial Neoplasms 5Thoracic Neoplasms 4Respiratory Tract Neoplasms 3Respiratory Tract Diseases 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms by Site 3Lung Diseases 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Adenocarcinoma of Lung 3Adenocarcinoma 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Noonan Syndrome 2Non Small Cell Lung Cancer Metastatic 2Neoplasms, Nerve Tissue 2

Interventions

Blood Specimen Collection 9Liquid Biopsy 4cabazitaxel 3Trastuzumab 3Surgical Procedures, Operative 3Propofol 3Bevacizumab 3Standard of Care 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Morphine 2Laparoscopy 2Folfox protocol 2Epirubicin 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1osimertinib 1jinfukang 1eribulin 1Zoledronic Acid 1Vinorelbine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplastic Cells, Circulating × osimertinib × Clear all
NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Second Affiliated Hospital of Nanchang University

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡